Photo of Ghayas Issa from faculty.mdanderson.org
Jun 19, 2024, 22:24
Fadi Haddad: Ghayas Issa presenting the results of AUGMENT-101
Fadi Haddad, Assistant Professor of the Leukemia Department at MD Anderson Cancer Center, Houston, shared a post on X/Twitter:
“Ghayas Issa from MD Anderson Cancer Center presenting the results of AUGMENT-101:
- N=57 evaluable for efficacy
- KMT2Ar leukemias
- Heavily pretreated patients, 46% with >3 prior lines
- CR/CRh=23%, mOS=8 months
- No discontinuation due to DS”
Source: Fadi Haddad/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18
Dec 21, 2024, 11:12
Dec 21, 2024, 11:06
Dec 21, 2024, 10:38